A conversation with Terrence Kalley, founder of Freedom of Access to Medicines (FAMEDS), regarding patient advocacy and his organization's fight against FDA's plans to remove the metastatic breast cancer indication for Avastin, a biologic drug produced and marketed by Genentech/Roche.
Sorry we couldn't complete your registration. Please try again.
Please enter your email to finish creating your account.
Receive a personalized list of podcasts based on your preferences.